Clovis Oncology

Clovis spikes ovarian cancer combo after 'underwhelming' efficacy; Servier wins priority review for Tibsovo expansion
Endpoints
Wed, 05/5/21 - 10:42 am
Clovis Oncology
earnings
Lucitanib
Opdivo
Bristol Myers Squibb
ovarian cancer
Clovis Oncology completes target enrollment in ATHENA trial in advanced ovarian cancer
Pharmaceutical Business Review
Thu, 06/11/20 - 11:16 am
Clovis Oncology
clinical trials
Rubraca
ovarian cancer
Opdivo
Bristol-Myers Squibb
Biotech companies raise cash as coronavirus updates lift stocks
BioPharma Dive
Tue, 05/19/20 - 11:24 pm
biotech
biotech stocks
COVID-19
Moderna Therapeutics
Bluebird Bio
Turning Point Therapeutics
Gossamer Bio
Krystal Biotech
Clovis Oncology
Gamida Cell
Bellerophon
Cash-strapped Clovis bums out investors with $85M offering
Fierce Pharma
Tue, 05/19/20 - 11:17 pm
Clovis Oncology
Clovis steals march on AZ with PARP prostate approval
Pharmaforum
Mon, 05/18/20 - 10:44 am
Clovis Oncology
prostate cancer
Rubraca
FDA
From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now
Motley Fool
Thu, 05/7/20 - 10:46 am
FDA
drug approvals
Gilead Sciences
remdesivir
AstraZeneca
Merck
Lynparza
Clovis Oncology
Rubraca
Bristol-Myers Squibb
Opdivo
Yervoy
Positive Prostate Cancer Results for Lynparza Are Bad News for Clovis Oncology
Motley Fool
Mon, 04/27/20 - 07:27 pm
Clovis Oncology
Rubraca
AstraZeneca
Merck
Lynparza
prostate cancer
Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today
Motley Fool
Tue, 04/21/20 - 12:07 am
Clovis Oncology
Immunomedics
Puma Biotechnology
cancer
Clovis Oncology's Sales Growth Slows in Q4
Motley Fool
Tue, 02/25/20 - 10:05 am
Clovis Oncology
earnings
FDA Gives Clovis Oncology's Rubraca a Priority Review
Motley Fool
Wed, 01/15/20 - 11:06 pm
Clovis Oncology
Rubraca
FDA
priority review
Will Clovis’ Rubraca sales shortfall revive talk of a buyout at JP Morgan?
Fierce Pharma
Wed, 01/8/20 - 12:09 pm
Clovis Oncology
Rubraca
M&A
JPMHC 2020
Clovis Oncology Reports Preliminary Fourth Quarter Sales of Rubraca and Sells Additional Shares
Motley Fool
Tue, 01/7/20 - 11:05 pm
Clovis Oncology
earnings
Is Clovis Oncology Really a Buyout Candidate?
Motley Fool
Tue, 12/3/19 - 10:21 pm
Clovis Oncology
M&A
Rubraca
oncology
Clovis' Rubraca, trailing PARP rivals, nabs England coverage thanks to NICE U-turn
Fierce Pharma
Sat, 10/12/19 - 12:32 pm
Clovis Oncology
Rubraca
NICE
UK
PARP inhibitors
Clovis shares plunge after downgrade raises questions on path forward
Biopharma Dive
Wed, 09/25/19 - 09:15 am
Clovis Oncology
Rubraca
Clovis strikes 3B deal to move into radiopharmaceuticals
Fierce Biotech
Mon, 09/23/19 - 10:42 am
Clovis Oncology
radiopharmaceuticals
3B Pharmaceuticals
AstraZeneca Success On Prostate Cancer Drug Lowers Enthusiasm For Clovis
Yahoo/Benzinga
Wed, 08/14/19 - 10:13 am
AstraZeneca
Clovis Oncology
prostate cancer
Lynparza
Clovis investors feel more Lynparza pressure
EP Vantage
Thu, 08/8/19 - 10:51 am
prostate cancer
Lynparza
Rubraca
Clovis Oncology
AstraZeneca
Merck
Clovis investors lose faith as Rubraca struggles against Big Pharma's marketing giants
Fierce Pharma
Fri, 08/2/19 - 12:43 pm
Clovis Oncology
Rubraca
PARP inhibitors
Clovis Focuses on Rubraca Label Expansion, Competition Stiff
Yahoo/Zacks.com
Thu, 04/18/19 - 10:25 pm
Clovis Oncology
Rubraca
ovarian cancer

Pages